1-201058407-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PVS1_ModeratePM2
The NM_000069.3(CACNA1S):c.3609+1G>A variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000062 in 1,613,466 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000069.3 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA1S | NM_000069.3 | c.3609+1G>A | splice_donor_variant, intron_variant | Intron 28 of 43 | ENST00000362061.4 | NP_000060.2 | ||
CACNA1S | XM_005245478.4 | c.3609+1G>A | splice_donor_variant, intron_variant | Intron 28 of 42 | XP_005245535.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152234Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000795 AC: 2AN: 251472Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135918
GnomAD4 exome AF: 0.00000547 AC: 8AN: 1461232Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 726964
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152234Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74372
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant summary: CACNA1S c.3609+1G>A is located in a canonical splice-site and is predicted to affect mRNA splicing resulting in a significantly altered protein due to either exon skipping, shortening, or inclusion of intronic material. Several computational tools predict a significant impact on normal splicing: Four predict the variant abolishes a 5' splicing donor site. However, these predictions have yet to be confirmed by functional studies. Although a heterozygous loss-of-function variant has been reported in a patient affected with Hypokalaemic periodic paralysis (HOKPP; e.g., PMID 34777470), loss of function is not an established disease mechanism for HOKPP and Malignant Hyperthermia Susceptibility (MHS) (see e.g. PMID 33746731). The variant allele was found at a frequency of 2.1e-05 in 473476 control chromosomes (i.e., 10 heterozygotes; gnomAD and jMorp (Tadaka_2021) databases). The observed variant frequency is approximately 17 fold of the estimated maximal expected allele frequency for a pathogenic variant in CACNA1S causing Hypokalemic Periodic Paralysis phenotype (1.3e-06), suggesting that the variant may be benign. To our knowledge, no occurrence of c.3609+1G>A in individuals affected with Hypokalemic Periodic Paralysis and no experimental evidence demonstrating its impact on protein function have been reported. The following publication was ascertained in the context of this evaluation (PMID: 33179747). No submitters have reported clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at